Outcomes of non-high grade serous carcinoma after neoadjuvant chemotherapy for advanced-stage ovarian cancer: a Korean gynecologic oncology group study (OV 1708)-Reference-Cited by-同舟云学术

Outcomes of non-high grade serous carcinoma after neoadjuvant chemotherapy for advanced-stage ovarian cancer: a Korean gynecologic oncology group study (OV 1708)

Published:2019-04-11 Issue:1 Volume:19 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Chung Young Shin,Park Sang-Yoon,Lee Jung-Yun,Park Jeong-Yeol,Lee Jeong-Won,Kim Hee Seung,Suh Dong Soo,Kim Yun Hwan,Lee Jong-Min,Kim Miseon,Choi Min Chul,Shim Seung-Hyuk,Lee Keun Ho,Song Taejong,Hong Jin Hwa,Lee Won Moo,Lee Banghyun,Lee In Ho

Funder

National Research Foundation of Korea

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-019-5514-7.pdf

Reference34 articles.

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7–30.

2. Lim MC, Moon EK, Shin A, Jung KW, Won YJ, Seo SS, et al. Incidence of cervical, endometrial, and ovarian cancer in Korea, 1999-2010. J Gynecol Oncol. 2013;24:298–302.

3. Lee JY, Kim EY, Jung KW, Shin A, Chan KK, Aoki D, et al. Trends in gynecologic cancer mortality in east Asian regions. J Gynecol Oncol. 2014;25:174–82.